367 related articles for article (PubMed ID: 25808408)
1. Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice.
NguyenThai QA; Sharma N; Luong do H; Sodhi SS; Kim JH; Kim N; Oh SJ; Jeong DK
J Gene Med; 2015; 17(3-5):87-99. PubMed ID: 25808408
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma.
Kosaka H; Ichikawa T; Kurozumi K; Kambara H; Inoue S; Maruo T; Nakamura K; Hamada H; Date I
Cancer Gene Ther; 2012 Aug; 19(8):572-8. PubMed ID: 22744211
[TBL] [Abstract][Full Text] [Related]
3. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
4. The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase.
Chang DY; Yoo SW; Hong Y; Kim S; Kim SJ; Yoon SH; Cho KG; Paek SH; Lee YD; Kim SS; Suh-Kim H
Int J Cancer; 2010 Oct; 127(8):1975-83. PubMed ID: 20473873
[TBL] [Abstract][Full Text] [Related]
5. Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.
Chung T; Na J; Kim YI; Chang DY; Kim YI; Kim H; Moon HE; Kang KW; Lee DS; Chung JK; Kim SS; Suh-Kim H; Paek SH; Youn H
Theranostics; 2016; 6(10):1477-90. PubMed ID: 27446484
[TBL] [Abstract][Full Text] [Related]
6. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells.
Matuskova M; Baranovicova L; Kozovska Z; Durinikova E; Pastorakova A; Hunakova L; Waczulikova I; Nencka R; Kucerova L
J Gene Med; 2012 Dec; 14(12):776-87. PubMed ID: 23150190
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
Krassikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
J Gene Med; 2016 Sep; 18(9):220-33. PubMed ID: 27461566
[TBL] [Abstract][Full Text] [Related]
10. A preliminary study on the construction of double suicide gene delivery vectors by mesenchymal stem cells and the in vitro inhibitory effects on SKOV3 cells.
Jiang J; Wei D; Sun L; Wang Y; Wu X; Li Y; Fang Z; Shang H; Wei Z
Oncol Rep; 2014 Feb; 31(2):781-7. PubMed ID: 24317390
[TBL] [Abstract][Full Text] [Related]
11. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy.
Kucerova L; Altanerova V; Matuskova M; Tyciakova S; Altaner C
Cancer Res; 2007 Jul; 67(13):6304-13. PubMed ID: 17616689
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model.
Kucerova L; Skolekova S; Demkova L; Bohovic R; Matuskova M
Gene Ther; 2014 Oct; 21(10):874-87. PubMed ID: 25056607
[TBL] [Abstract][Full Text] [Related]
13. Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene.
Ramnaraine M; Pan W; Goblirsch M; Lynch C; Lewis V; Orchard P; Mantyh P; Clohisy DR
Cancer Res; 2003 Oct; 63(20):6847-54. PubMed ID: 14583482
[TBL] [Abstract][Full Text] [Related]
14. [Experimental studies on the treatment of colon cancer by cytosine deaminase gene and 5-fluorocytosine].
Huang JH; Wang Y; Li CH; Zhong DG; Lü HY
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):6-8. PubMed ID: 15771788
[TBL] [Abstract][Full Text] [Related]
15. The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model.
Fei S; Qi X; Kedong S; Guangchun J; Jian L; Wei Q
J Cancer Res Clin Oncol; 2012 Feb; 138(2):347-57. PubMed ID: 22139383
[TBL] [Abstract][Full Text] [Related]
16. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.
Kang NH; Hwang KA; Yi BR; Lee HJ; Jeung EB; Kim SU; Choi KC
Cancer Gene Ther; 2012 Jun; 19(6):412-9. PubMed ID: 22498724
[TBL] [Abstract][Full Text] [Related]
17. Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma.
Altanerova V; Cihova M; Babic M; Rychly B; Ondicova K; Mravec B; Altaner C
Int J Cancer; 2012 May; 130(10):2455-63. PubMed ID: 21732344
[TBL] [Abstract][Full Text] [Related]
18. Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
Kazlauskas A; Darinskas A; Meškys R; Tamašauskas A; Urbonavičius J
BMC Cancer; 2019 Mar; 19(1):197. PubMed ID: 30832616
[TBL] [Abstract][Full Text] [Related]
19. Increased proliferation and chemosensitivity of human mesenchymal stromal cells expressing fusion yeast cytosine deaminase.
Kucerova L; Poturnajova M; Tyciakova S; Matuskova M
Stem Cell Res; 2012 Mar; 8(2):247-58. PubMed ID: 22265744
[TBL] [Abstract][Full Text] [Related]
20. Cytosine deaminase/5-fluorocytosine exposure induces bystander and radiosensitization effects in hypoxic glioblastoma cells in vitro.
Chen JK; Hu LJ; Wang D; Lamborn KR; Deen DF
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1538-47. PubMed ID: 17394949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
